HRR Gene Panel (Germline) is a genetic test that examines inherited mutations in genes involved in homologous recombination repair, a key DNA repair pathway. It is done to identify a person’s hereditary risk for certain cancers, especially breast, ovarian, prostate, and pancreatic cancers, and to help guide genetic counseling, cancer screening, and preventive care decisions.
HRR stands for homologous recombination repair, which is a DNA repair mechanism in the body.
It is a genetic risk test, not a direct cancer detection test, but it helps identify inherited cancer predisposition.
People with a personal or family history of cancer, especially breast, ovarian, prostate, or pancreatic cancer, may be advised to take it.
No, a positive result means you may have an inherited gene change that increases cancer risk.
A negative result means no mutation was found in the tested genes, but it does not completely rule out cancer risk.
Certainly, it is often used as a preventive genetic test in people at high risk.